Similar articles for PMID: 14609621

Year	Number of Results
1998	7
1999	26
2000	24
2001	22
2002	16
2003	23
2004	10
2005	17
2006	13
2007	12
2008	5
2009	5
2010	3
2011	2
2012	3
2013	2
2014	1
2017	1
2020	5
2021	6
2022	1
2023	4
2024	1

1

Sildenafil in patients with cardiovascular disease.

Brindis RG, Kloner RA. Brindis RG, et al. Am J Cardiol. 2003 Nov 6;92(9A):26M-36M. doi: 10.1016/s0002-9149(02)03368-4. Am J Cardiol. 2003. PMID: 14609621 Review.

2

Overall cardiovascular profile of sildenafil citrate.

Zusman RM, Morales A, Glasser DB, Osterloh IH. Zusman RM, et al. Am J Cardiol. 1999 Mar 4;83(5A):35C-44C. doi: 10.1016/s0002-9149(99)00046-6. Am J Cardiol. 1999. PMID: 10078541 Review.

3

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.

Wallis RM, Corbin JD, Francis SH, Ellis P. Wallis RM, et al. Am J Cardiol. 1999 Mar 4;83(5A):3C-12C. doi: 10.1016/s0002-9149(99)00042-9. Am J Cardiol. 1999. PMID: 10078537

4

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.

Conti CR, Pepine CJ, Sweeney M. Conti CR, et al. Am J Cardiol. 1999 Mar 4;83(5A):29C-34C. doi: 10.1016/s0002-9149(99)00045-4. Am J Cardiol. 1999. PMID: 10078540

5

Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.

De Young L, Yu D, Freeman D, Brock GB. De Young L, et al. Int J Impot Res. 2003 Oct;15(5):347-54. doi: 10.1038/sj.ijir.3901026. Int J Impot Res. 2003. PMID: 14562136

6

Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.

Corbin JD, Francis SH, Webb DJ. Corbin JD, et al. Urology. 2002 Sep;60(2 Suppl 2):4-11. doi: 10.1016/s0090-4295(02)01686-2. Urology. 2002. PMID: 12414329 Review.

7

Cardiovascular effects of sildenafil citrate and recommendations for its use.

Kloner RA, Zusman RM. Kloner RA, et al. Am J Cardiol. 1999 Sep 9;84(5B):11N-17N. doi: 10.1016/s0002-9149(99)00114-9. Am J Cardiol. 1999. PMID: 10503571 Review.

8

Effects of sildenafil citrate on human hemodynamics.

Jackson G, Benjamin N, Jackson N, Allen MJ. Jackson G, et al. Am J Cardiol. 1999 Mar 4;83(5A):13C-20C. doi: 10.1016/s0002-9149(99)00043-0. Am J Cardiol. 1999. PMID: 10078538 Clinical Trial.

9

Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.

Jackson G, Montorsi P, Cheitlin MD. Jackson G, et al. Urology. 2006 Sep;68(3 Suppl):47-60. doi: 10.1016/j.urology.2006.05.047. Urology. 2006. PMID: 17011375 Review.

10

Phosphodiesterase-5 inhibitors and their hemodynamic effects.

Prisant LM. Prisant LM. Curr Hypertens Rep. 2006 Aug;8(4):345-51. doi: 10.1007/s11906-006-0075-y. Curr Hypertens Rep. 2006. PMID: 16884667 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

201 results

Results by year